T. Rowe Price Associates’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
134,514
+8,961
| +7% | +$8.79K | ﹤0.01% | 2834 |
|
|
2025
Q1 | $181K | Buy |
125,553
+1,657
| +1% | +$2.39K | ﹤0.01% | 2680 |
|
|
2024
Q4 | $273K | Buy |
123,896
+16,404
| +15% | +$36.1K | ﹤0.01% | 2539 |
|
|
2024
Q3 | $178K | Hold |
107,492
| – | – | ﹤0.01% | 2690 |
|
|
2024
Q2 | $239K | Buy |
107,492
+72,092
| +204% | +$160K | ﹤0.01% | 2522 |
|
|
2024
Q1 | $95K | Hold |
35,400
| – | – | ﹤0.01% | 2792 |
|
|
2023
Q4 | $106K | Hold |
35,400
| – | – | ﹤0.01% | 2710 |
|
|
2023
Q3 | $35K | Buy |
35,400
+19,800
| +127% | +$19.6K | ﹤0.01% | 2810 |
|
|
2023
Q2 | $22K | Sell |
15,600
-14,164
| -48% | -$20K | ﹤0.01% | 2858 |
|
|
2023
Q1 | $48K | Buy |
29,764
+1,122
| +4% | +$1.81K | ﹤0.01% | 2795 |
|
|
2022
Q4 | $178K | Buy |
28,642
+1,415
| +5% | +$8.79K | ﹤0.01% | 2568 |
|
|
2022
Q3 | $183K | Buy |
27,227
+9,408
| +53% | +$63.2K | ﹤0.01% | 2574 |
|
|
2022
Q2 | $113K | Buy |
17,819
+728
| +4% | +$4.62K | ﹤0.01% | 2725 |
|
|
2022
Q1 | $79K | Buy |
+17,091
| New | +$79K | ﹤0.01% | 2870 |
|
|
2021
Q4 | – | Sell |
-22,522
| Closed | -$271K | – | 2998 |
|
|
2021
Q3 | $271K | Buy |
22,522
+5,000
| +29% | +$60.2K | ﹤0.01% | 2609 |
|
|
2021
Q2 | $371K | Buy |
17,522
+480
| +3% | +$10.2K | ﹤0.01% | 2506 |
|
|
2021
Q1 | $478K | Buy |
17,042
+6,976
| +69% | +$196K | ﹤0.01% | 2385 |
|
|
2020
Q4 | $262K | Sell |
10,066
-3,100
| -24% | -$80.7K | ﹤0.01% | 2470 |
|
|
2020
Q3 | $489K | Sell |
13,166
-172,161
| -93% | -$6.39M | ﹤0.01% | 2098 |
|
|
2020
Q2 | $9.51M | Sell |
185,327
-15,515
| -8% | -$796K | ﹤0.01% | 1304 |
|
|
2020
Q1 | $6.33M | Buy |
200,842
+157,446
| +363% | +$4.96M | ﹤0.01% | 1297 |
|
|
2019
Q4 | $2.59M | Sell |
43,396
-297,631
| -87% | -$17.7M | ﹤0.01% | 1538 |
|
|
2019
Q3 | $12.5M | Buy |
341,027
+5,115
| +2% | +$188K | ﹤0.01% | 1252 |
|
|
2019
Q2 | $15.6M | Sell |
335,912
-129,645
| -28% | -$6.03M | ﹤0.01% | 1237 |
|
|
2019
Q1 | $18.7M | Buy |
465,557
+168,884
| +57% | +$6.78M | ﹤0.01% | 1192 |
|
|
2018
Q4 | $13.6M | Sell |
296,673
-6,363
| -2% | -$293K | ﹤0.01% | 1252 |
|
|
2018
Q3 | $13.4M | Buy |
303,036
+133
| +0% | +$5.9K | ﹤0.01% | 1322 |
|
|
2018
Q2 | $11.9M | Buy |
302,903
+8,059
| +3% | +$316K | ﹤0.01% | 1318 |
|
|
2018
Q1 | $21.3M | Buy |
294,844
+104,757
| +55% | +$7.58M | ﹤0.01% | 1157 |
|
|
2017
Q4 | $12.5M | Buy |
190,087
+111,723
| +143% | +$7.36M | ﹤0.01% | 1286 |
|
|
2017
Q3 | $3.93M | Sell |
78,364
-3,183
| -4% | -$160K | ﹤0.01% | 1449 |
|
|
2017
Q2 | $3.77M | Sell |
81,547
-12,570
| -13% | -$582K | ﹤0.01% | 1447 |
|
|
2017
Q1 | $3.32M | Sell |
94,117
-3,500
| -4% | -$124K | ﹤0.01% | 1478 |
|
|
2016
Q4 | $1.22M | Sell |
97,617
-2,443
| -2% | -$30.6K | ﹤0.01% | 1706 |
|
|
2016
Q3 | $1.39M | Buy |
100,060
+4,020
| +4% | +$55.7K | ﹤0.01% | 1634 |
|
|
2016
Q2 | $949K | Sell |
96,040
-545
| -0.6% | -$5.39K | ﹤0.01% | 1722 |
|
|
2016
Q1 | $1.63M | Hold |
96,585
| – | – | ﹤0.01% | 1571 |
|
|
2015
Q4 | $2.15M | Buy |
96,585
+7,313
| +8% | +$163K | ﹤0.01% | 1524 |
|
|
2015
Q3 | $2.11M | Hold |
89,272
| – | – | ﹤0.01% | 1539 |
|
|
2015
Q2 | $7.3M | Sell |
89,272
-35,372
| -28% | -$2.89M | ﹤0.01% | 1414 |
|
|
2015
Q1 | $11.5M | Buy |
+124,644
| New | +$11.5M | ﹤0.01% | 1300 |
|